GlassScriptPhysician profile
Kathryn A Knodel
NPI 1750416020
$2,145.25
in general payments reported to CMS, 2019-2025
27 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $300 · 2021: $191 · 2022: $524 · 2023: $210 · 2024: $263 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581 · Education: $230 · Gift: $8.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.94 |
| Education | $229.94 |
| Gift | $8.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $487.00 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $291.24 | 2019-2022 | |
| Channel Medsystems, INC. | $162.89 | 2022-2024 | |
| Novo Nordisk INC | $152.44 | 2020-2023 | |
| Hologic Sales and Service, LLC | $120.75 | 2019-2023 | Aptima |
| Pfizer INC. | $111.48 | 2019-2023 | |
| Coopersurgical, INC. | $79.70 | 2019-2022 | |
| Exeltis, USA INC. | $68.93 | 2020-2025 | Slynd |
| Biogen, INC. | $68.32 | 2024-2025 | Zurzuvae |
| Dysis Medical, INC. | $64.72 | 2022 | |
| Mayne Pharma Commercial LLC | $56.37 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.37 | 2021-2025 | |
| Organon LLC | $48.32 | 2021-2024 | |
| Millicent US INC | $45.00 | 2025 | |
| Therapeuticsmd, INC. | $41.72 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $41.66 | 2019 | |
| Davol INC. | $38.28 | 2024 | Arista Ah Flexitip |
| Myovant Sciences INC. | $37.24 | 2022 | |
| Minerva Surgical, INC | $37.03 | 2025 | |
| Baxter Healthcare | $32.62 | 2025 | Perclot |
| Sumitomo Pharma America, INC. | $18.98 | 2025 | Gemtesa |
| Shield Therapeutics INC | $16.85 | 2025 | |
| Axonics, INC. | $15.55 | 2021 | |
| Roche Diagnostics Corporation | $14.23 | 2019 | |
| Lsi Solutions INC | $13.49 | 2025 | Fornisee |
| Evofem Biosciences, INC. | $12.57 | 2021 | |
| Agile Therapeutics, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Knodel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.